| Place of Origin: | China |
|---|---|
| Brand Name: | ChineseHormone |
| Certification: | ISO9001,SGS,UKAS |
| Model Number: | Follistatin 344 |
| Minimum Order Quantity: | 1 vials |
| Price: | negotiated |
| Packaging Details: | as your required |
| Delivery Time: | 3-7 working days |
| Payment Terms: | Western Union, MoneyGram, T/T, Bitcoin |
| Supply Ability: | 500g / month |
| Purity: | 99.0% | Speciication: | 1mg / Vial |
|---|---|---|---|
| Alias: | FST, FS | Stored Desiccated: | Below -18°C |
| Molecular Formula: | C13H16O3 | Appearence: | White Lyophilized (freeze-dried) Powder |
| Email: | Tonyraws810@gmail.com | Whatsapp: | 86-15871352379 |
| Wickr: | Tonyraws | ||
| High Light: | muscle building peptides,growth hormone peptides |
||
Follistatin 344(FST, FS) Hormone Peptide for Bodybuilding Freeze-Dried 1mg / Vial
| Name: |
Follistatin 344
|
| Synonyms: |
FST, FS, Activin-binding protein.
|
| Appearance: |
Sterile Filtered White Lyophilized (Freeze-Dried)
|
| Purity (by HPLC): |
99.00%
|
| Source: |
Escherichia Coli
|
| Formulation |
Lyophilized from a concentrated (1mg / ml) solution containing no additives.
|
| Solubility: | It is recommended to reconstitute the lyophilized Follistatin in sterile 18MΩ-cm H2O not less than 100μg / ml, which can then be further diluted to other aqueous solutions. |
| Stability: | Lyophilized Follistatin although stable at room temperature for 3 weeks.For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles. |
| Purity: | Greater than 95.0% as determined by (a) Analysis by RP-HPLC (b) Analysis by SDS-PAGE..Storage Conditions: Aviod Shunshine and Keeping Stoppered |
.Operational Mechanics of Follistatin 344
Follistatin 344 is an autocrine glyocoprotein that is expressed in nearly every tissue that is found within animal test subjects. It is occasionally referred to as Activin-binding Protein or FST. It possesses a molecular weight of 36KDa, and its molecular formula is C13H16O3.
According to scientific study based on animal test subjects, the primary function of Follistatin 344 is to bind and bioneutralize members of the TGF-β superfamily; a large group of structurally related cell regulatory proteins. The peptide has been shown to have a particular focus on activin, a protein complex that works to enhance follicle stimulating hormone biosynthesis and secretion. Studies have indicated that Follistatin 344 binds directly to activin and works specifically as an activin antagonist to inhibit the biosynthesis and secretion of follicle-stimulating hormone (FSH)
The roots of Follistatin 344’s overall functionality can be traced back to the solliculostellate (FS) cells of the anterior pituitary gland. This is the pea-sized gland that is located at the bottom of the hypothalamus at the base of the brain and is chiefly responsible for the control and regulation of several endocrine-related operations in an animal test subject’s body.
The connection that Follistatin 344 has with the cells is based on the fact that the presence of the peptide has been demonstrated to play a key role in the regulatory control of cellular proliferation. In essence, Follistatin 344 works to protect an animal test subject’s body from uncontrolled cellular growth.
At the same time, the peptide acts an instrument of cellular differentiation; that is, the process in which a non-specialized cellular unit becomes a more specialized cell type. According to scientific study conducted on animal test subjects, it has been determined that both of these functions play a key role in tissue building and tissue repair. This determination has led some studies to conclude that this particular aspect of functionality correlates to the peptide’s elevated presence in the skin.
It has also been determined through scientific study that Follistatin 344 plays an active role in the blood of animal test subjects. Specifically, it has been known to invoke an inflammatory response, meaning that its presences plays a role in triggering the complex biological response of vascular tissues to irritants, pathogens, damaged cells, or other potentially harmful stimuli.
While it has not yet been determined where exactly the peptide generates in circulating blood plasma, it has been theorized that because of its autocrine characteristic, it may come from the endothelial cells, which are the thin layer of cells that align the inner surface of blood vessels. It has also been suggested that the peptide may originate from the white blood cells known as monocytes and or the macrophages.
Any needs, please contact me
Email: tonyraws810@gmail.com
Whatsapp: 86-15871352379
Wickr: tonyraws
